+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prognostic factors for disease-free survival in pT2N0 non-small cell lung cancer



Prognostic factors for disease-free survival in pT2N0 non-small cell lung cancer



Asian Cardiovascular and Thoracic Annals 14(2): 139-144



To clarify the prognostic factors for disease-free survival in completely resected pT2N0 non-small cell lung cancer, 81 consecutive patients who were treated between 1998 and 2001 were retrospectively reviewed. Follow-up was complete for all patients and the median follow-up time was 37.5 months. The overall 5-year survival rate was 68.6%, and the 5-year disease-free survival rate was 62.5%. Four factors (age, sex, visceral pleural invasion, and administration of tegafur and uracil) were proposed as prognostic factors for disease-free survival by univariate analysis. In multivariate analysis, visceral pleural invasion by the tumor (hazard ratio = 2.709, 95% confidence interval: 1.085 to 6.765, p = 0.033) and administration of tegafur and uracil (hazard ratio = 0.327, 95% confidence interval: 0.147 to 0.730, p = 0.006) were significant factors. Visceral pleural invasion was a prognostic factor for reduced disease-free survival in completely resected pT2N0 non-small cell lung cancer, and postoperative treatment with tegafur and uracil significantly improved disease-free survival.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 050036051

Download citation: RISBibTeXText

PMID: 16551822

DOI: 10.1177/021849230601400212


Related references

Prognostic Factors as a Function of Disease-free Interval After Definitive (Chemo)radiation for Non-Small Cell Lung Cancer Using Conditional Survival Analysis. American Journal of Clinical Oncology 41(1): 46-52, 2018

Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival. Journal of Thoracic and Cardiovascular Surgery 134(3): 638-643, 2007

Genetic alterations of driver genes as independent prognostic factors for disease-free survival in patients with resected non-small cell lung cancer. Lung Cancer 128: 152-157, 2019

Recurrence-free survival and prognostic factors in resected pN2 non-small cell lung cancer. European Journal of Cardio-Thoracic Surgery 22(5): 695-700, 2002

Loss of 4q21.23-22.1 is a prognostic marker for disease free and overall survival in non-small cell lung cancer. Plos one 9(12): E113315, 2014

RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer. Journal of Clinical Oncology 22(10): 1878-1885, 2004

A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer. Journal of Translational Medicine 17(1): 152, 2019

Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer. Medical Oncology 30(1): 352, 2013

Five-year survival analysis and prognostic factors in patients operated on for non-small cell lung cancer with N2 disease. Journal of Thoracic Disease 10(6): 3180-3186, 2018

Pretreatment prognostic factors for survival in small-cell lung cancer: a new prognostic index and validation of three known prognostic indices on 341 patients. Annals of Oncology 8(6): 547-553, 1997

Prognostic value of preoperative metabolic tumor volumes on PET-CT in predicting disease-free survival of patients with stage I non-small cell lung cancer. Anticancer Research 32(11): 5087-5091, 2012

Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study. European Journal of Cancer 51(17): 2534-2544, 2015

Progression-free survival: an important prognostic marker for long-term survival of small cell lung cancer. Tuberculosis and Respiratory Diseases 76(5): 218-225, 2014

Survival and prognostic factors in small cell lung cancer. Medical Oncology 27(1): 73-81, 2010

CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification. Journal of Thoracic Oncology 5(5): 649-657, 2010